Qingguo Lu
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Empty Sella and Cushing's Disease: Lessons Learned from a Diagnostically Challenging Case.
Journal: Neuro endocrinology letters
Published: September 21, 2025
Gut microbiota: a potential therapeutic target for hyperuricemia and gout.
Journal: Bioscience of microbiota, food and health
Published: June 20, 2025
Clinical guidelines on physical activity and exercise therapy for Chinese adults with type 2 diabetes: A clinical practice guideline from the Chinese Society of Endocrinology.
Journal: Journal of sport and health science
Published: February 26, 2025
Expert consensus on personalized initiation of glucose-lowering therapy in adults with newly diagnosed type 2 diabetes without clinical cardiovascular disease or chronic kidney disease.
Journal: Journal of evidence-based medicine
Published: January 17, 2022
Not the final diagnosis: from Addison's disease to POEMS syndrome: a case report and literature review.
Journal: The Journal of international medical research
Published: December 21, 2021
Coexistence of Graves' disease and primary hyperparathyroidism: a case description.
Journal: Quantitative imaging in medicine and surgery
Published: September 28, 2021
Direct Cardiac Actions of the Sodium Glucose Co-Transporter 2 Inhibitor Empagliflozin Improve Myocardial Oxidative Phosphorylation and Attenuate Pressure-Overload Heart Failure.
Journal: Journal of the American Heart Association
Published: March 15, 2021
Empagliflozin Ameliorates Obesity-Related Cardiac Dysfunction by Regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet-Induced Obese Mice.
Journal: Diabetes
Published: October 02, 2019
Empagliflozin attenuates ischemia and reperfusion injury through LKB1/AMPK signaling pathway.
Journal: Molecular and cellular endocrinology
Published: September 27, 2019
AMPK: a balancer of the renin-angiotensin system.
Journal: Bioscience reports
Published: November 16, 2018
AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases.
Journal: Bioscience reports
Published: November 04, 2018
Dichloroacetate Ameliorates Cardiac Dysfunction Caused by Ischemic Insults Through AMPK Signal Pathway-Not Only Shifts Metabolism.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: October 30, 2018
Last Updated: 09/26/2026